CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.
about
Is lipid signaling through cannabinoid 2 receptors part of a protective system?The CB2 receptor and its role as a regulator of inflammationImpact of Cannabis, Cannabinoids, and Endocannabinoids in the LungsCannabinoid CB2 receptor potentiates obesity-associated inflammation, insulin resistance and hepatic steatosisTargeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis.Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.Cannabinoid receptor 2 signaling does not modulate atherogenesis in miceUnraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and diseaseCannabinoid receptor type 2 (CB2) deficiency alters atherosclerotic lesion formation in hyperlipidemic Ldlr-null miceRegulation of inflammation by cannabinoids, the endocannabinoids 2-arachidonoyl-glycerol and arachidonoyl-ethanolamide, and their metabolites.Cannabinoid receptor type-2 stimulation, blockade, and deletion alter the vascular inflammatory responses to traumatic brain injury.Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells.CB1 and CB2 cannabinoid receptors differentially regulate the production of reactive oxygen species by macrophages.HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions.Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritisLigand-based virtual screening identifies a family of selective cannabinoid receptor 2 agonists.Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor.Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis.Update on the role of cannabinoid receptors after ischemic stroke.Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation.Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression.Pleiotropic effects of the CB2 cannabinoid receptor activation on human monocyte migration: implications for atherosclerosis and inflammatory diseases.Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2.Human lung-resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factorsAttenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists.Modulating the endocannabinoid system in human health and disease--successes and failuresModulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitationsRole of the endocannabinoid system in diabetes and diabetic complications.The role of the endocannabinoid system in atherosclerosis.Cannabinoid receptor CB2 protects against balloon-induced neointima formation.Neuroimmune interactions and pain: focus on glial-modulating targetsCannabinoid receptor type 2 activation induces a microglial anti-inflammatory phenotype and reduces migration via MKP induction and ERK dephosphorylation.Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrierThe emerging role of the endocannabinoid system in cardiovascular disease.Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies?Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV- adultsPathophysiological role of inflammatory molecules in paediatric ischaemic brain injury.Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation.
P2860
Q24633122-FD399220-0BA5-4312-AAB8-B8948D0480B7Q28066700-A52BB8EE-5758-42E6-9100-C3055DAFF7A5Q28077958-5D9FD68E-BE49-4951-BA57-C5D615E019DAQ33464957-818861BA-067B-46F2-9EA2-18B6E81D9CACQ33655394-7A234E22-DC6C-4A18-9892-151F065F7F2AQ33755251-AFC70F1F-8110-4C09-9DBD-AC260EDF01B3Q33889311-E5A2607B-E3D7-477B-A57B-62CFAA5A7F1CQ34188446-37E9C93A-AA11-4334-AEDE-6B5C16F36487Q34238768-667D5A3A-61BF-4A1C-AC26-DD50982232E4Q34471868-F19F4EF1-CB5E-4CE2-BB45-970D25CA6011Q34591087-72A98B04-09C5-4524-9484-DDEB7710E0C9Q34624990-E2C76847-3E2B-4576-950D-19967F4A4C8CQ34992040-5A32F840-3EEF-405C-B7D6-7D29E2E57188Q34993393-9EAB96D4-2D11-452A-82F8-76F8A52EB7CFQ35179985-853704F6-8359-454E-BA89-EBA611E01FBEQ35223319-DE8CFC5B-D013-405E-BEFC-3DFA1216EEF7Q35501238-CD7217D5-6426-4F05-8668-C3D8BE14C60EQ35672413-CDB2C877-2EB3-4D99-9287-C5314F3DE953Q35766665-453B9054-F3E4-4735-A4C4-000B0F23DBFBQ35915645-F6CC0B51-5AAC-4B2D-B010-0BD3F882822BQ36036102-A55AC72D-5F8A-490E-A718-1735AC2E2E9FQ36346915-A66AD457-6CE5-4DEC-B041-F7F0B52F6B4EQ36370835-FA3CB665-2C72-4FA0-908C-794EFF9B6DE4Q36496316-78FF6D8A-5A67-4F9E-9891-B5DDB6F9738AQ36551447-A96BD36D-471F-4392-BC4C-585EA08BB643Q36676002-78A1941E-1CBD-468C-B04D-A33631C7765CQ36775401-2DA83731-814A-4CFA-8846-F5FD89AABD1EQ36933683-1EC07FE6-1DEA-43A6-8EEF-C167A3F830FEQ36940347-84F40970-C7F3-4ECF-BC8D-504A2BEEF02EQ37085532-A26DC0F1-12C9-4980-ACE9-69A6830D5046Q37143578-121ED0AF-ADA3-46E3-B818-38AE066BDF22Q37174735-5C79C5DC-86B1-46A5-A39C-4030C18A7086Q37207178-8A68D0EB-3F6F-4F95-8015-B64D79E2CC03Q37246426-6CD1830B-7533-453F-A70A-67B7CB34734CQ37271987-F1074623-7AB4-4E4C-B15C-80FE4C3C87C5Q37439386-4B893111-E9B9-4C0B-BE3E-9DDA93EC78EBQ37546194-731DD35C-99B3-4DAE-980C-3BEEA9CA29DAQ37589006-C742C242-5C3F-4D9F-9C77-B5FE25835B51Q37976090-D600BE26-8AD8-413C-961D-13756EC70D4CQ38087533-6940C306-32CC-4978-9342-8DE4C78CCA86
P2860
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@ast
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@en
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@nl
type
label
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@ast
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@en
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@nl
prefLabel
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@ast
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@en
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@nl
P2860
P921
P1476
CB2 cannabinoid receptor agoni ...... racellular signaling pathways.
@en
P2093
François Mach
Sabine Steffens
P2860
P304
P356
10.1152/AJPHEART.01328.2007
P577
2008-01-04T00:00:00Z